Home / health news / BBNS : reported that Leerink Swann Reaffirms Market Perform Rating for TESARO Inc (TSRO)
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

BBNS : reported that Leerink Swann Reaffirms Market Perform Rating for TESARO Inc (TSRO)

referring to Leerink Swann reiterated their market perform rating on shares of TESARO Inc (NASDAQ:TSRO) in a research note published on Monday.
TRADEMARK VIOLATION NOTICE: “Leerink Swann Reaffirms Market Perform Rating for TESARO Inc (TSRO)” was reported by BBNS and is the property of of BBNS.
The stock presently has an average rating of Buy and an average target price of $160.27.
Interwest Venture Management Co. acquired a new stake in shares of TESARO during the fourth quarter valued at approximately $271,838,000.
Perceptive Advisors LLC acquired a new stake in shares of TESARO during the fourth quarter valued at approximately $92,521,000.

according to

The TESARO Inc (TSRO) Receives Market Perform Rating from Leerink Swann

The TESARO Inc (TSRO) Receives Market Perform Rating from Leerink Swann

Leerink Swann reiterated their market perform rating on shares of TESARO Inc (NASDAQ:TSRO) in a research report sent to investors on Monday.
TESARO Company ProfileTESARO, Inc is an oncology-focused biopharmaceutical company.
Finally, Capital Fund Management S.A. bought a new position in TESARO during the third quarter worth approximately $681,000.
First Trust Advisors LP bought a new position in TESARO during the third quarter worth approximately $464,000.
Peregrine Capital Management LLC bought a new position in TESARO during the third quarter worth approximately $11,066,000.

according to

The TESARO Inc (TSRO) Stock Rating Lowered by Zacks Investment Research

Get a free copy of the Zacks research report on TESARO (TSRO)For more information about research offerings from Zacks Investment Research, visit Zacks.com
TESARO Inc (NASDAQ:TSRO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday.
Leerink Swann cut TESARO from an “outperform” rating to a “market perform” rating and set a $186.00 price target on the stock.
Wedbush restated an “outperform” rating and issued a $139.00 price target on shares of TESARO in a research report on Wednesday, December 21st.
Cowen and Company set a $155.00 price target on TESARO and gave the company a “hold” rating in a research report on Saturday, February 25th.

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

A new recommendation to reduce the number of shots for children of HPV vaccine

according to “This vaccine should have been introduced as a vaccine that will prevent cancer, …